MeSH term
Frequency | Condition_Probility | Amino Acid Sequence | 8 | 0.0 |
Cell Line | 4 | 0.0 |
Humans | 14 | 0.0 |
RNA Interference | 2 | 0.0 |
Research Support, Non-U.S. Gov't | 11 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 6 | 0.0 |
Ubiquitins/*metabolism | 2 | 1.0 |
Animals | 4 | 0.0 |
Cell Cycle Proteins/*metabolism | 5 | 1.0 |
Cells, Cultured | 2 | 0.0 |
*Cullin Proteins | 8 | 12.0 |
Mice | 2 | 0.0 |
Peptide Synthases/*metabolism | 2 | 6.0 |
SKP Cullin F-Box Protein Ligases | 4 | 10.0 |
Transcription Factors/*metabolism | 2 | 0.0 |
Carcinoma, Renal Cell/*genetics | 2 | 2.0 |
Carrier Proteins/*genetics | 3 | 0.0 |
Chromosome Mapping | 2 | 0.0 |
DNA Mutational Analysis | 2 | 0.0 |
Kidney Neoplasms/*genetics | 2 | 0.0 |
*Ligases | 6 | 3.0 |
Macromolecular Substances | 3 | 0.0 |
Proteins/*metabolism | 2 | 0.0 |
*Tumor Suppressor Proteins | 6 | 0.0 |
*Ubiquitin-Protein Ligases | 7 | 1.0 |
Comparative Study | 3 | 0.0 |
Genes, Tumor Suppressor/*genetics | 2 | 0.0 |
Models, Molecular | 3 | 0.0 |
Molecular Sequence Data | 7 | 0.0 |
Protein Conformation | 2 | 0.0 |
Sequence Analysis, DNA | 3 | 0.0 |
Adult | 3 | 0.0 |
Aged | 2 | 0.0 |
Cell Cycle Proteins/*genetics | 2 | 1.0 |
Female | 2 | 0.0 |
Male | 2 | 0.0 |
Middle Aged | 3 | 0.0 |
Polymorphism, Single-Stranded Conformational | 3 | 0.0 |
Cell Hypoxia | 2 | 1.0 |
Mutation | 4 | 0.0 |
Protein Binding | 3 | 0.0 |
*Saccharomyces cerevisiae Proteins | 2 | 0.0 |
Sequence Alignment | 2 | 0.0 |
Adolescent | 2 | 0.0 |
Child | 2 | 0.0 |
Hippel-Lindau Disease/*genetics | 2 | 1.0 |
Loss of Heterozygosity | 2 | 0.0 |
Protein Structure, Tertiary | 2 | 0.0 |
